To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Sir Thomas Fulton Wilson McKillop, born March 19, 1943, is a chemist, pharmaceutical company CEO and chairman of NatWest.
Additional recommended knowledge
McKillop was born in Dreghorn, a small village near the town or Irvine in Ayrshire and educated at Irvine Royal Academy and then Glasgow University, where he took a BSc Hons and PhD in Chemistry. He joined ICI's Corporate Research Laboratory at Runcorn in 1969 after post-doctoral research work in Paris. He moved to ICI Pharmaceuticals Division in 1975 and, having held a number of positions in Research, in 1989 he was appointed Technical Director of ICI Pharmaceuticals with international responsibility for research, development and production.
In 1993, ICI Pharmaceuticals demerged to become Zeneca, and in 1994 he was appointed Chief Executive Officer of the new company. In April 1999, Zeneca merged with Astra to form AstraZeneca PLC and McKillop became Chief Executive of the merged company. He retired on the 1st January 2006, when David Brennan took over the role of AstraZeneca CEO.
McKillop is Chairman of the Royal Bank of Scotland and a was a non-executive director of Lloyds TSB Group plc from 1999-2004. He is also Chairman of the British Pharma Group, Pro-Chancellor of the University of Leicester, Vice-President of the European Federation of Pharmaceutical Industries and Associations and Chairman of the North West Science Council. He was awarded the Society of Chemical Industry's annual Centenary Medal in 2005. In January 2007 he took up the post of President of the Science Council.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tom_McKillop". A list of authors is available in Wikipedia.|